Target intelligence / Profile preview

Platelet membrane glycoprotein

Molecular classification
Integrin family (e.g., αIIbβ3/GPIIb/IIIa, α2β1/GPIa/IIa), Immunoglobulin-like adhesion receptor (e.g., GPVI), Leucine-rich glycoprotein complex (e.g., GPIb/V/IX), Selectin family (P-selectin)
01

Overview

Platelet membrane glycoproteins are a diverse group of surface proteins found on platelets that play essential roles in hemostasis by mediating platelet adhesion to damaged blood vessels and promoting platelet–platelet cohesion during clot formation. The major classes include integrins such as αIIbβ3 (GPIIb/IIIa), which binds fibrinogen and is central to aggregation; the GPIb/V/IX complex that binds von Willebrand factor for initial adhesion; collagen receptors like GPIa/IIa and GPVI; and other receptors including P-selectin. These molecules act as therapeutic targets for antithrombotic drugs but can also be implicated in inherited bleeding disorders when defective. Their function is tightly regulated through interactions with extracellular matrix proteins and intracellular signaling pathways. Note: "Platelet glycoproteins" refers collectively to several distinct protein complexes rather than a single molecule. For structured data purposes, it may be necessary to specify individual members such as "Integrin alpha-IIb beta 3" or "Glycoprotein Ib alpha" if more granularity is required.

Other names
Platelet glycoproteinsPlatelet surface glycoproteinsGP (with specific complexes such as GPIIb/IIIa, GPIb-IX-V, etc.)
02

Mechanism of action

Inhibition of fibrinogen binding to integrin αIIbβ3 prevents platelet aggregation and thrombus formation

03

Biological functions

HemostasisPlatelet adhesionPlatelet aggregationSignal transduction in platelet activation
04

Disease associations

Cardiovascular disease (thrombosis, myocardial infarction)Bleeding disorders (Glanzmann thrombasthenia, Bernard-Soulier syndrome)
05

Safety considerations

Increased bleeding risk with inhibition or deficiency
06

Interacting drugs

Abciximab

2 more in the full profile.

07

Biomarkers

Expression levels or function of specific glycoproteins for diagnosis of Glanzmann thrombasthenia or Bernard-Souliere syndrome

Beyond the preview

Go deeper on Platelet membrane glycoprotein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Platelet membrane glycoprotein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call